February 10, 2026 at 8:00 AM
Biodefense Blind Spot: Why Washington Confuses Pandemics with Bioweapons
The next great biological threat may not begin in a wet market, a jungle, or a laboratory accident. It may begin on a laptop with a commercially available AI model.In October 2025, AI researchers from Microsoft reported...
The next great biological threat may not begin in a wet market, a jungle, or a laboratory accident. It may begin on a laptop with a commercially available AI model.In October 2025, AI researchers from Microsoft reported that generative AI tools could design dangerous proteins capable of evading biosecurity and, alarmingly, could slip past the screening systems used by DNA manufacturers.In February 2025, researchers at Arc Institute released Evo 2, an AI model trained on 128,000 genomes that can design entirely new organisms. The model achieves 90 percent accuracy in predicting which genetic mutations cause disease.
Within weeks of its predecessor’s release in 2024, users had circumvented biosecurity safeguards by adding back viral data that developers had deliberately excluded. The same month, Anthropic reported its Claude Opus 4 model could significantly enhance the ability of novices to plan bioweapon production, triggering the company’s highest security protocols for the first time. OpenAI’s o3 model, released in April 2025, can assist experts in effectively planning operations for reproducing a recognized biological threat.These are not speculative futures.